US 8507437
Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same
granted A61KA61K38/1709A61K38/1761
Quick answer
US patent 8507437 (Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/1709, A61K38/1761, A61P, A61P29/00